Problems with Using Women's Cancer Screening Rates to Measure Performance
Paul A. Heineken, MD, Cheryl Wenell, RNP, MS, Karla Kerlikowske, MD, and Louise C. Walter, MD
Dr. Heineken is the associate chief of staff of ambulatory care, Ms. Wenell is the coordinator of the Women Veterans Program, Dr. Kerlikowske is the director of the Women's Clinic, and Dr. Walter is a staff physician, all at the San Francisco VA Medical Center, San Francisco, CA. In addition, Dr. Heineken is a clinical professor in the School of Medicine, Ms. Wenell is an associate clinical professor in the School of Nursing, Dr. Kerlikowske is a professor in residence in the departments of medicine and epidemiology and biostatistics in the School of Medicine, and Dr. Walter is an associate professor in the division of geriatrics and the codirector of the Geriatrics Research Program in the School of Medicine, all at the University of California, San Francisco.
When a VA audit determined that the San Francisco VA Medical Center had underperformed with regard to breast and cervical cancer screening, these authors reviewed the medical charts of patients who were counted as screening failures. Their findings point to flaws with the VA’s auditing process and its use of women’s cancer screening rates as performance measures.
Recommended Reading
Clinical Topics
-
Is early-onset cancer an emerging global epidemic? -
Cost paramount when choosing metastatic breast cancer treatment Publish date: September 30, 2022 -
Genetic tests create treatment opportunities and confusion for breast cancer patients Publish date: September 22, 2022 -
Time to cancer diagnoses in U.S. averages 5 months Publish date: September 15, 2022 -
Single Institution Retrospective Review of Patterns of Care and Disease Presentation in Female Veterans With Breast Cancer During the COVID-19 Pandemic
Digital Edition
-
Publish date: July 5, 2023
-
Publish date: March 30, 2022
-
Publish date: September 22, 2021
-
Publish date: September 3, 2021
-
Publish date: May 20, 2021
Multimedia
-
Data underscore the importance of lifestyle interventions in breast cancer patients Publish date: December 17, 2018 -
Publish date: December 14, 2018
-
Extending Therapy for Breast Cancer Publish date: September 3, 2014
Conference Coverage
-
Cannabis in Cancer: What Oncologists and Patients Should Know Publish date: October 23, 2024 -
Identifying Barriers in Germline Genetic Testing Referrals for Breast Cancer: A Single-Center Experience -
Asynchronous Bilateral Breast Cancer in a Male Patient -
National Tele-Oncology High-Risk Breast Clinic Program -
Circulating Tumor DNA Hints at BC Recurrence Risk Publish date: July 24, 2024 -
Eribulin Similar to Taxane When Paired With Dual HER2 Blockade in BC Publish date: July 10, 2024 -
Clinical Controversy: Standard Dose or Baby TAM for Breast Cancer Prevention? Publish date: July 5, 2024 -
MUC-1 vaccine associated with notable overall survival rates in breast cancer Publish date: June 27, 2024 -
Platinum Add-On Improves Survival in Early TNBC Publish date: June 25, 2024 -
One Patient Changed This Oncologist’s View of Hope. Here’s How. Publish date: June 19, 2024
USPSTF Breast Cancer Screening Recommendations
